5 Key Takeaways
-
1
Optometrists have transitioned from referral gatekeepers to active partners in the longitudinal care of retinal diseases.
-
2
Approximately 90% of patients with neovascular age-related macular degeneration maintain vision with anti-VEGF treatment.
-
3
Monitoring tools for optometrists include OCT, best-corrected visual acuity, Amsler grid testing, and contrast sensitivity.
-
4
Persistent intraretinal fluid is critical to monitor as it correlates with photoreceptor damage and poorer visual outcomes.
-
5
Optometrists should maintain communication with retina specialists, providing cumulative patient history and monitoring adherence.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


